The Netherlands
Devices for treatment


Out-of-hospital cardiac arrests (OHCAs) are a major health problem in Europe and in the United States with 280.000 OHCAs and 180.000 OHCAs occuring every year respectively in those regions. Despite that these are OHCAs that are attended by emergency medical services, the survival rate to hospital discharge remains low with an average rate of 9.6%.



The European Registry of Cardiac arrest predicts that giving timely and qualitative chest-compression could save tens of thousands of lives each year. It is proven that the currently available mechanical CPR machines are not superior to manual compression. This limits their use and adoption rate by hospitals and emergency medical services.



Philips has developed the Jiminy, a mechanical compression device that addresses the shortcomings of the current products. This includes improved stability provided by the patented backboard and personalized compression location, adjustable depth and frequency. The proprietary algorithm measures the pulse and compression and gives feedback to the caretaker to signal adjustments when necessary. These features of an aCPR ensure a more timely and better quality compression, superior to current products on the market. Jiminy may even prove superior to manual compression.


First preclinical tests (on pigs) have been carried out with the current prototype. The prototype needs to be adapted to prepare it for the next step: first in human and the subsequent clinical validation of the device.

Meet the team

Pieter Wijffels (1)

Pieter Wijffels

Venture Partner

Prior to joining NLC as a Venture Partner, Pieter spent 15 years at Philips, bringing innovation to life across the globe. He enjoys working in fast paced environments and supporting initiatives that truly improve the lives of people.